Novel self-assembling nanoparticle from irinotecan shows high anti-tumor efficacy in pancreatic cancer

被引：0
|
作者：
Zhang, L. [1 ]
Wang, W. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
Nanoparticle; irinotecan; pancreatic cancer;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-273
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [41] A Novel Chimeric Poxvirus Encoding an Anti-PD-L1 Protein Shows Safety and Anti-Tumor Activity in Breast Cancer Model
    Chaurasiya, Shyambabu
    Lu, Jianming
    Kim, Sang-In
    Warner, Susanne G.
    Woo, Yanghee
    Chen, Nanhai G.
    Fong, Yuman
    MOLECULAR THERAPY, 2019, 27 (04) : 192 - 192
  • [42] Targeting NPC1L1 rescues anti-tumor immunity and improves immunotherapeutic efficacy in pancreatic cancer
    Liang, H.
    Ou, J.
    Chen, Z.
    Zi, R.
    Shen, K.
    Zheng, P.
    Su, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S912 - S913
  • [43] Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape
    Lee, Ji Eun
    Kang, Yeo Wool
    Jung, Kyung Hee
    Son, Mi Kwon
    Shin, Seung-Min
    Kim, Ji-Sun
    Kim, Soo Jung
    Fang, Zhenghuan
    Yan, Hong Hua
    Park, Jung Hee
    Yoon, Young-Chan
    Han, Boreum
    Cheon, Min Ji
    Woo, Min Gyu
    Seo, Myung Sung
    Lim, Joo Han
    Kim, Yong-Sung
    Hong, Soon-Sun
    CANCER LETTERS, 2021, 507 : 97 - 111
  • [44] High Tumor Mutational Burden Identifies Specific Subsets of Pancreatic Cancer Patients with Prolonged Survival and Improved Anti-tumor Immunity
    Karamitopoulou-Diamantis, Eva
    Andreou, Andreas
    Wenning, Anna-Silvia
    Gloor, Beat
    Perren, Aurel
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1223 - 1224
  • [45] High Tumor Mutational Burden Identifies Specific Subsets of Pancreatic Cancer Patients with Prolonged Survival and Improved Anti-tumor Immunity
    Karamitopoulou-Diamantis, Eva
    Andreou, Andreas
    Wenning, Anna-Silvia
    Gloor, Beat
    Perren, Aurel
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1223 - 1224
  • [46] Self-assembling porphyrin conjugate-carboplatin(IV) prodrug nanoparticles for enhancing high efficacy nasopharyngeal cancer and low systemic toxicity
    Su, Renjie
    Zhang, Xiangwen
    Peng, Qianhua
    Wang, Wenbin
    JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2022, 33 (14) : 1828 - 1844
  • [47] LBL-019, a novel anti-TNFR2 antibody, shows a potent anti-tumor efficacy in a mouse MC38 model.
    Lin, Huan
    Huang, Xiao
    Qin, Yurong
    Dang, Yujia
    Zhang, Peng
    Sun, Jianming
    Guan, Jing
    Lai, Shoupeng
    Kang, Xiaoqiang
    Ling, Hong
    CANCER RESEARCH, 2022, 82 (12)
  • [48] FoRx-06-428 is a novel PARG inhibitor with potent anti-tumor efficacy in preclinical cancer models
    Querolle, Olivier
    Lucking, Ulrich
    Iacovino, Luca
    Freudenmann, Alena
    Rossetti, Giacomo
    Gysin, Marina
    Bologna, Serena
    Dionellis, Vasilis
    Malattia, Marta
    Potenza, Alessandro
    Bocquet, Nicolas
    Konstantinova, Irena
    Goutopoulos, Andreas
    Sotiriou, Sotirios
    Halazonetis, Thanos
    Bashir, Tarig
    Zenke, Frank
    CANCER RESEARCH, 2024, 84 (06)
  • [49] The potent quadruplex-binding compound QN302 shows anti-tumor activity as a monotherapy in an orthotopic in vivo model of pancreatic cancer
    Williams, Nicole
    Santos, Danielle
    Worthington, Jenny
    Ahmed, Ahmed
    Arshad, Tariq
    Neidle, Stephen
    CANCER RESEARCH, 2023, 83 (07)
  • [50] A novel SDC1-targeted therapeutic antibody inhibits macropinocytosis and induces anti-tumor immunity in pancreatic cancer
    Yang, Zecheng
    Theardy, Madelaine S.
    Chen, Shuaitong
    Wei, Yongkun
    Takeda, Mitsunobu
    Wang, Xiaofei
    Yao, Jun
    Li, Jennifer
    Park, Jangho
    Zheng, Yangxi
    Vien, Long T.
    Bover, Laura
    Ying, Haoqiang
    Yao, Wantong
    CANCER RESEARCH, 2024, 84 (17)
12345